Halozyme Reports First Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Halozyme Reports First Quarter 2017 Financial Results

Halozyme Therapeutics (HALO) Misses Q1 EPS by 1c; Reiterates Outlook

May 9, 2017 4:28 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q1 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $30.85 million.

Financial Outlook for 2017

For 2017, the company reiterated its financial guidance of:

Net revenue of $115... More